Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 147 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia. A nested case-control study. JAMA Intern Med 2019:24 de junio. [Ref.ID 103160]
2. Cita con resumen
Varga S, Alcusky M, Keith SW, Hegarty SE, Del Canale S, Lombardi M, Maio V. Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults. Br J Clin Pharmacol 2017;83:2572-80. [Ref.ID 102117]
4. Cita con resumen
Anonimo. Study 329: Why is it so important?. Therapeutics Initiative 1016:1-2. [Ref.ID 100955]
5.
Anónimo. Drugs for depression. Med Lett Drugs Ther 2016;58:85-90. [Ref.ID 100883]
6.Tiene citas relacionadas Cita con resumen
Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881-90. [Ref.ID 100612]
7. Cita con resumen
Anónimo. QT interval and drug therapy. Drug Ther Bull 2016;54:33-6. [Ref.ID 100134]
9.Tiene citas relacionadas Cita con resumen
Shin J-Y, Park M-J, Lee SH, Choi S-H, Kim M-H, Choi N-K, Lee J, Park B-J. Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study. BMJ 2015;351:h3517. [Ref.ID 99249]
10. Cita con resumen
Anónimo. Incontinences urinaires d'origine médicamenteuse. Prescrire 2015;35:271-4. [Ref.ID 99126]
11.Tiene citas relacionadas Cita con resumen
Coupland C, Hill TMorriss R, Arthur A, Moore M, Hippisley-Cox J. Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database. BMJ 2015;350:h517. [Ref.ID 98877]
12.Tiene citas relacionadas Cita con resumen
Sinyor M, Cheung AH. Antidepressants and risk of suicide. BMJ 2015;350:h783. [Ref.ID 98876]
13. Cita con resumen
Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ 2014;348:g1626. [Ref.ID 97343]
14.
Caldwell PHY, Deshpande AV, Von Gontard A. Management of nocturnal enuresis. BMJ 2013;347:28-32. [Ref.ID 96476]
15. Cita con resumen
Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]
16. Cita con resumen
López E, Fraile S, Hidalgo FJ, García B. Posible síndrome neuroléptico maligno asociado a aripiprazol e imipramina tratado con bromocriptina. Med Clin (Barc) 2013;141:273-4. [Ref.ID 96080]
17.
Anónimo. An update on the drug treatment of neuropathic pain. Part 1: antidepressants. Drug Ther Bull 2012;50:114-7. [Ref.ID 93823]
18. Cita con resumen
Khoza S, Barner JC, Bohman TM, Rascati K, Lawson K, Wilson JP. Use of antidepressant agents and the risk of type 2 diabetes. Eur J Clin Pharmacol 2012;68:1295-302. [Ref.ID 93647]
19.
Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012;379:1045-55. [Ref.ID 92526]
20. Cita con resumen
Hatcher S, Arroll B. Newer antidepressants for the treatment of depression in adults. BMJ 2012;344:45-9. [Ref.ID 92299]
Seleccionar todas
 
 1 a 20 de 147 siguiente >>